Decreased Extracellular Adenosine Levels Lead to Loss of Hypoxia-Induced Neuroprotection after Repeated Episodes of Exposure to Hypoxia

PLoS ONE

Volumn 8, Issue 2, 2013, Pages

  Cui, Mei ^b   Bai, Xue ^a   Li, Tianfu ^c   Chen, Fangzhe ^b   Dong, Qiang ^b   Zhao, Yanxin ^a   Liu, Xueyuan ^a  

^a TENTH PEOPLE S HOSPITAL OF TONGJI UNIVERSITY   (China)

^b FUDAN UNIVERSITY   (China)

^c CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

5' NUCLEOTIDASE; 8 CYCLOPENTYL 1,3 DIPROPYLXANTHINE; ADENOSINE; ADENOSINE A1 RECEPTOR; ADENOSINE A2A RECEPTOR; CD39 ANTIGEN; EQUILIBRATIVE NUCLEOSIDE TRANSPORTER 1; HEMOGLOBIN; HYPOXIA INDUCIBLE FACTOR; MESSENGER RNA; PROPENTOFYLLINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD PRESSURE MEASUREMENT; BRAIN BLOOD FLOW; BRAIN HYPOXIA; CONTROLLED STUDY; GENE EXPRESSION REGULATION; HEART STROKE VOLUME; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HYPOXIA INDUCIBLE FACTOR GENE; IN VIVO STUDY; ISCHEMIC PRECONDITIONING; LEUKOCYTE COUNT; MICRODIALYSIS; MIDDLE CEREBRAL ARTERY OCCLUSION; MOUSE; NEUROPROTECTION; NONHUMAN; POLYMERASE CHAIN REACTION; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; TRANSIENT ISCHEMIC ATTACK;

5'-NUCLEOTIDASE; ADENOSINE; ANIMALS; ANOXIA; ANTIGENS, CD; APYRASE; CEREBROVASCULAR CIRCULATION; EQUILIBRATIVE NUCLEOSIDE TRANSPORT PROTEINS; EXTRACELLULAR SPACE; HYPOXIA-INDUCIBLE FACTOR 1; ISCHEMIC ATTACK, TRANSIENT; ISCHEMIC PRECONDITIONING; MALE; MICE; NEURONS; NEUROPROTECTIVE AGENTS; RECEPTOR, ADENOSINE A1; REGIONAL BLOOD FLOW; XANTHINES;

EID: 84874340131     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0057065     Document Type: Article

References (63)

1. Johnston SC, Gress DR, Browner WS, Sidney S, (2000) Short-term prognosis after emergency department diagnosis of TIA. JAMA 284: 2901-2906.
2. Johnston SC, Rothwell PM, Nguyen-Huynh MN, Giles MF, Elkins JS, et al. (2007) Validation and refinement of scores to predict very early stroke risk after transient ischaemic attack. Lancet 369: 283-292.
3. Correia M, Silva MR, Magalhaes R, Guimaraes L, Silva MC, (2006) Transient ischemic attacks in rural and urban northern Portugal: incidence and short-term prognosis. Stroke 37: 50-55.
4. Prass K, Scharff A, Ruscher K, Lowl D, Muselmann C, et al. (2003) Hypoxia-induced stroke tolerance in the mouse is mediated by erythropoietin. Stroke 34: 1981-1986.
5. Li YX, Ding SJ, Xiao L, Guo W, Zhan Q, (2008) Desferoxamine preconditioning protects against cerebral ischemia in rats by inducing expressions of hypoxia inducible factor 1 alpha and erythropoietin. Neurosci Bull 24: 89-95.
6. Jones NM, Kardashyan L, Callaway JK, Lee EM, Beart PM, (2008) Long-term functional and protective actions of preconditioning with hypoxia, cobalt chloride, and desferrioxamine against hypoxic-ischemic injury in neonatal rats. Pediatr Res 63: 620-624.
7. Sharp FR, Ran R, Lu A, Tang Y, Strauss KI, et al. (2004) Hypoxic preconditioning protects against ischemic brain injury. NeuroRx 1: 26-35.
8. Wick A, Wick W, Waltenberger J, Weller M, Dichgans J, et al. (2002) Neuroprotection by hypoxic preconditioning requires sequential activation of vascular endothelial growth factor receptor and Akt. J Neurosci 22: 6401-6407.
9. Cunha RA, (2005) Neuroprotection by adenosine in the brain: From A(1) receptor activation to A (2A) receptor blockade. Purinergic Signal 1: 111-134.
10. Dunwiddie TV, Masino SA, (2001) The role and regulation of adenosine in the central nervous system. Annu Rev Neurosci 24: 31-55.
11. Lin TN, He YY, Wu G, Khan M, Hsu CY, (1993) Effect of brain edema on infarct volume in a focal cerebral ischemia model in rats. Stroke 24: 117-121.
12. Li X, Blizzard KK, Zeng Z, DeVries AC, Hurn PD, et al. (2004) Chronic behavioral testing after focal ischemia in the mouse: functional recovery and the effects of gender. Exp Neurol 187: 94-104.
13. Zhao Y, Rempe DA, (2011) Prophylactic neuroprotection against stroke: low-dose, prolonged treatment with deferoxamine or deferasirox establishes prolonged neuroprotection independent of HIF-1 function. J Cereb Blood Flow Metab 31: 1412-1423.
14. Cui M, Aras R, Christian WV, Rappold PM, Hatwar M, et al. (2009) The organic cation transporter-3 is a pivotal modulator of neurodegeneration in the nigrostriatal dopaminergic pathway. Proc Natl Acad Sci U S A 106: 8043-8048.
15. Cui M, Tang X, Christian WV, Yoon Y, Tieu K, (2010) Perturbations in mitochondrial dynamics induced by human mutant PINK1 can be rescued by the mitochondrial division inhibitor mdivi-1. J Biol Chem 285: 11740-11752.
16. Kolar F, Jezkova J, Balkova P, Breh J, Neckar J, et al. (2007) Role of oxidative stress in PKC-delta upregulation and cardioprotection induced by chronic intermittent hypoxia. Am J Physiol Heart Circ Physiol 292: H224-230.
17. Parkinson FE, Zhang YW, Shepel PN, Greenway SC, Peeling J, et al. (2000) Effects of nitrobenzylthioinosine on neuronal injury, adenosine levels, and adenosine receptor activity in rat forebrain ischemia. J Neurochem 75: 795-802.
18. Fredholm BB, Chen JF, Cunha RA, Svenningsson P, Vaugeois JM, (2005) Adenosine and brain function. Int Rev Neurobiol 63: 191-270.
19. Eltzschig HK, Ibla JC, Furuta GT, Leonard MO, Jacobson KA, et al. (2003) Coordinated adenine nucleotide phosphohydrolysis and nucleoside signaling in posthypoxic endothelium: role of ectonucleotidases and adenosine A2B receptors. J Exp Med 198: 783-796.
20. Eltzschig HK, Eckle T, Mager A, Kuper N, Karcher C, et al. (2006) ATP release from activated neutrophils occurs via connexin 43 and modulates adenosine-dependent endothelial cell function. Circ Res 99: 1100-1108.
21. Fredholm BB, (2007) Adenosine, an endogenous distress signal, modulates tissue damage and repair. Cell Death Differ 14: 1315-1323.
22. Kitakaze M, Hori M, Morioka T, Minamino T, Takashima S, et al. (1994) Infarct size-limiting effect of ischemic preconditioning is blunted by inhibition of 5′-nucleotidase activity and attenuation of adenosine release. Circulation 89: 1237-1246.
23. Kim HH, Sawada N, Soydan G, Lee HS, Zhou Z, et al. (2008) Additive effects of statin and dipyridamole on cerebral blood flow and stroke protection. J Cereb Blood Flow Metab 28: 1285-1293.
24. Zhang D, Xiong W, Albensi BC, Parkinson FE, (2011) Expression of human equilibrative nucleoside transporter 1 in mouse neurons regulates adenosine levels in physiological and hypoxic-ischemic conditions. J Neurochem 118: 4-11.
25. Oberdorster G, Lang R, Zimmer R, (1972) [Effect of theophylline on the vascular resistance of cerebral vessels during normal and restricted circulation and adenosine perfusion]. Pflugers Arch 332: Suppl 332: R359.
26. Khorasani MZ, Hajizadeh S, Fathollahi Y, Semnanian S, (2006) Interaction of adenosine and naloxone on regional cerebral blood flow in morphine-dependent rats. Brain Res 1084: 61-66.
27. Hart ML, Gorzolla IC, Schittenhelm J, Robson SC, Eltzschig HK, (2010) SP1-dependent induction of CD39 facilitates hepatic ischemic preconditioning. J Immunol 184: 4017-4024.
28. Montminy M, (1997) Transcriptional regulation by cyclic AMP. Annu Rev Biochem 66: 807-822.
29. Lovatt D, Xu Q, Liu W, Takano T, Smith NA, et al. (2012) Neuronal adenosine release, and not astrocytic ATP release, mediates feedback inhibition of excitatory activity. Proc Natl Acad Sci U S A 109: 6265-6270.
30. Leisewitz AV, Zimmerman EI, Huang M, Jones SZ, Yang J, et al. (2011) Regulation of ENT1 expression and ENT1-dependent nucleoside transport by c-Jun N-terminal kinase. Biochem Biophys Res Commun 404: 370-375.
31. Eltzschig HK, Abdulla P, Hoffman E, Hamilton KE, Daniels D, et al. (2005) HIF-1-dependent repression of equilibrative nucleoside transporter (ENT) in hypoxia. J Exp Med 202: 1493-1505.
32. Parkinson FE, Rudolphi KA, Fredholm BB, (1994) Propentofylline: a nucleoside transport inhibitor with neuroprotective effects in cerebral ischemia. Gen Pharmacol 25: 1053-1058.
33. Gui L, Duan W, Tian H, Li C, Zhu J, et al. (2009) Adenosine A 2A receptor deficiency reduces striatal glutamate outflow and attenuates brain injury induced by transient focal cerebral ischemia in mice. Brain Res 1297: 185-193.
34. Olsson T, Cronberg T, Rytter A, Asztely F, Fredholm BB, et al. (2004) Deletion of the adenosine A1 receptor gene does not alter neuronal damage following ischaemia in vivo or in vitro. Eur J Neurosci 20: 1197-1204.
35. Melani A, Pantoni L, Bordoni F, Gianfriddo M, Bianchi L, et al. (2003) The selective A2A receptor antagonist SCH 58261 reduces striatal transmitter outflow, turning behavior and ischemic brain damage induced by permanent focal ischemia in the rat. Brain Res 959: 243-250.
36. Von Lubitz DK, Lin RC, Jacobson KA, (1995) Cerebral ischemia in gerbils: effects of acute and chronic treatment with adenosine A2A receptor agonist and antagonist. Eur J Pharmacol 287: 295-302.
37. Dirnagl U, Becker K, Meisel A, (2009) Preconditioning and tolerance against cerebral ischaemia: from experimental strategies to clinical use. Lancet Neurol 8: 398-412.
38. Gidday JM, (2006) Cerebral preconditioning and ischaemic tolerance. Nat Rev Neurosci 7: 437-448.
39. Yenari M, Kitagawa K, Lyden P, Perez-Pinzon M, (2008) Metabolic downregulation: a key to successful neuroprotection? Stroke 39: 2910-2917.
40. Stagliano NE, Perez-Pinzon MA, Moskowitz MA, Huang PL, (1999) Focal ischemic preconditioning induces rapid tolerance to middle cerebral artery occlusion in mice. J Cereb Blood Flow Metab 19: 757-761.
41. Bergeron M, Gidday JM, Yu AY, Semenza GL, Ferriero DM, et al. (2000) Role of hypoxia-inducible factor-1 in hypoxia-induced ischemic tolerance in neonatal rat brain. Ann Neurol 48: 285-296.
42. Sakanaka M, Wen TC, Matsuda S, Masuda S, Morishita E, et al. (1998) In vivo evidence that erythropoietin protects neurons from ischemic damage. Proc Natl Acad Sci U S A 95: 4635-4640.
43. Brines ML, Ghezzi P, Keenan S, Agnello D, de Lanerolle NC, et al. (2000) Erythropoietin crosses the blood-brain barrier to protect against experimental brain injury. Proc Natl Acad Sci U S A 97: 10526-10531.
44. Siren AL, Fratelli M, Brines M, Goemans C, Casagrande S, et al. (2001) Erythropoietin prevents neuronal apoptosis after cerebral ischemia and metabolic stress. Proc Natl Acad Sci U S A 98: 4044-4049.
45. Morishita E, Masuda S, Nagao M, Yasuda Y, Sasaki R, (1997) Erythropoietin receptor is expressed in rat hippocampal and cerebral cortical neurons, and erythropoietin prevents in vitro glutamate-induced neuronal death. Neuroscience 76: 105-116.
46. Ruscher K, Freyer D, Karsch M, Isaev N, Megow D, et al. (2002) Erythropoietin is a paracrine mediator of ischemic tolerance in the brain: evidence from an in vitro model. J Neurosci 22: 10291-10301.
47. Prass K, Ruscher K, Karsch M, Isaev N, Megow D, et al. (2002) Desferrioxamine induces delayed tolerance against cerebral ischemia in vivo and in vitro. J Cereb Blood Flow Metab 22: 520-525.
48. Jones NM, Bergeron M, (2001) Hypoxic preconditioning induces changes in HIF-1 target genes in neonatal rat brain. J Cereb Blood Flow Metab 21: 1105-1114.
49. Bernaudin M, Nedelec AS, Divoux D, MacKenzie ET, Petit E, et al. (2002) Normobaric hypoxia induces tolerance to focal permanent cerebral ischemia in association with an increased expression of hypoxia-inducible factor-1 and its target genes, erythropoietin and VEGF, in the adult mouse brain. J Cereb Blood Flow Metab 22: 393-403.
50. Wiessner C, Allegrini PR, Ekatodramis D, Jewell UR, Stallmach T, et al. (2001) Increased cerebral infarct volumes in polyglobulic mice overexpressing erythropoietin. J Cereb Blood Flow Metab 21: 857-864.
51. Adair TH, (2005) Growth regulation of the vascular system: an emerging role for adenosine. Am J Physiol Regul Integr Comp Physiol 289: R283-R296.
52. Feoktistov I, Ryzhov S, Zhong H, Goldstein AE, Matafonov A, et al. (2004) Hypoxia modulates adenosine receptors in human endothelial and smooth muscle cells toward an A2B angiogenic phenotype. Hypertension 44: 649-654.
53. Rudolphi KA, Schubert P, Parkinson FE, Fredholm BB, (1992) Neuroprotective role of adenosine in cerebral ischaemia. Trends Pharmacol Sci 13: 439-445.
54. Kohler D, Eckle T, Faigle M, Grenz A, Mittelbronn M, et al. (2007) CD39/ectonucleoside triphosphate diphosphohydrolase 1 provides myocardial protection during cardiac ischemia/reperfusion injury. Circulation 116: 1784-1794.
55. Pinsky DJ, Broekman MJ, Peschon JJ, Stocking KL, Fujita T, et al. (2002) Elucidation of the thromboregulatory role of CD39/ectoapyrase in the ischemic brain. J Clin Invest 109: 1031-1040.
56. Eckle T, Krahn T, Grenz A, Kohler D, Mittelbronn M, et al. (2007) Cardioprotection by ecto-5′-nucleotidase (CD73) and A2B adenosine receptors. Circulation 115: 1581-1590.
57. Synnestvedt K, Furuta GT, Comerford KM, Louis N, Karhausen J, et al. (2002) Ecto-5′-nucleotidase (CD73) regulation by hypoxia-inducible factor-1 mediates permeability changes in intestinal epithelia. J Clin Invest 110: 993-1002.
58. Parkinson FE, Xiong W, Zamzow CR, (2005) Astrocytes and neurons: different roles in regulating adenosine levels. Neurol Res 27: 153-160.
59. King AE, Ackley MA, Cass CE, Young JD, Baldwin SA, (2006) Nucleoside transporters: from scavengers to novel therapeutic targets. Trends Pharmacol Sci 27: 416-425.
60. Sebastiao AM, de Mendonca A, Moreira T, Ribeiro JA, (2001) Activation of synaptic NMDA receptors by action potential-dependent release of transmitter during hypoxia impairs recovery of synaptic transmission on reoxygenation. J Neurosci 21: 8564-8571.
61. Knutsen HK, Reinton N, Tasken KA, Hansson V, Eskild W, (1996) Regulation of protein kinase A subunits by cyclic adenosine 3′,5′-monophosphate in a mouse Sertoli cell line (MSC-1): induction of RII beta messenger ribonucleic acid is independent of continuous protein synthesis. Biol Reprod 55: 5-10.
62. Jones PA, Smith RA, Stone TW, (1998) Protection against hippocampal kainate excitotoxicity by intracerebral administration of an adenosine A2A receptor antagonist. Brain Res 800: 328-335.
63. Hoyte LC, Papadakis M, Barber PA, Buchan AM, (2006) Improved regional cerebral blood flow is important for the protection seen in a mouse model of late phase ischemic preconditioning. Brain Res 1121: 231-237.